Abstract
BACKGROUND: Patients with tooth sensitivity are frequently exposed to desensitizing agents on a regular basis. These agents might have an impact on the surface properties and color of existing oral restorations. Accordingly, this study aimed to investigate the color stability, surface microhardness, and surface roughness of resin-modified glass ionomer (RMGIC), amalgomer CR, nanohybrid, and bulk-fill resin composites restorative materials after frequent exposure to a desensitizing agent. Materials and Methods. One hundred and twenty specimens were prepared; 10 specimens for each restorative material were equally subdivided into control and desensitizing-agent-exposed groups in each test. Surface microhardness and surface roughness were evaluated using the Vickers microhardness tester and surface profilometer, respectively. The color change was measured by using a spectrophotometer using the CIE L (∗) a (∗) b (∗) formula. Surface topography was analyzed using a scanning electron microscope (SEM). The collected data were analyzed with Student's t-test, one-way ANOVA, and Tukey post hoc tests for pairwise comparison at a level of significance of 0.05. RESULT: The frequent use of a desensitizing agent significantly decreased surface hardness of RMGIC, amalgomer, and bulk-fill composite materials. However, nanohybrid composite exhibited a significant surface hardness increase. The surface roughness of RMGIC, amalgomer, and nanohybrid composite increased significantly. Meanwhile, the bulk-fill resin composite showed a nonsignificant decrease. Both RMGIC and amalgomer exhibited significantly higher values of color change in comparison to those of nanohybrid and bulk-fill composites. CONCLUSION: The bulk-fill composite seems to be more resistant to discoloration and surface topographical changes than other tested materials on frequent exposure to the desensitizing agent. However, this exposure may pose a negative impact on its surface hardness. Bulk-fill resin composite may be the most suitable esthetic restorative in patients who frequently use desensitizing agents.